Back to News
Mar 9, 2026 8:01 AM

Editas Medicine Q4 Earnings Assessment

Editas Medicine (NASDAQ:EDIT) reported its Q4 earnings results on Monday, March 9, 2026 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Editas Medicine beat estimated earnings by 75.0%, reporting an EPS of $-0.06 versus an estimate of $-0.24.

Revenue was down $5.86 million from the same period last year.

Overview of Past Earnings

During the previous quarter, ...